BRPI0909749A2 - uso de fotoiniciador para fabrico de medicamento para tratamento do ceratocone, da ectasia e fortalecimento da córnea - Google Patents

uso de fotoiniciador para fabrico de medicamento para tratamento do ceratocone, da ectasia e fortalecimento da córnea

Info

Publication number
BRPI0909749A2
BRPI0909749A2 BRPI0909749-0A BRPI0909749A BRPI0909749A2 BR PI0909749 A2 BRPI0909749 A2 BR PI0909749A2 BR PI0909749 A BRPI0909749 A BR PI0909749A BR PI0909749 A2 BRPI0909749 A2 BR PI0909749A2
Authority
BR
Brazil
Prior art keywords
photoinitiator
strengthening
ectasia
corneal
keratoconus
Prior art date
Application number
BRPI0909749-0A
Other languages
English (en)
Inventor
Dewoolfson Bruce
Devore Dale
Original Assignee
Euclid Systems Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euclid Systems Corporation filed Critical Euclid Systems Corporation
Publication of BRPI0909749A2 publication Critical patent/BRPI0909749A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

uso de fotoiniciador para o fabrico de medicamento para tratamento do ceratocone, da ectasia e fortalecimento da córnea. são descritos métodos de fortalecimento das propriedades 5 biomecânicas da córnea expondo a córnea à luz ultravioleta na presença de um fotoiniciador. estes métodos podem ser usados para tratar o ceratocone. podem também ser usados para tratar a ectasia a seguir a um procedimento cirúrgico ou fortalecer a córnea antes de um procedimento cirúrgico.
BRPI0909749-0A 2008-03-14 2009-03-10 uso de fotoiniciador para fabrico de medicamento para tratamento do ceratocone, da ectasia e fortalecimento da córnea BRPI0909749A2 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US6460008P 2008-03-14 2008-03-14
US61/064,600 2008-03-14
US6486408P 2008-03-31 2008-03-31
US61/064,864 2008-03-31
US7158008P 2008-05-07 2008-05-07
US61/071,580 2008-05-07
PCT/US2009/036636 WO2009114513A2 (en) 2008-03-14 2009-03-10 Ultraviolet irradiation to treat corneal weakness disorders

Publications (1)

Publication Number Publication Date
BRPI0909749A2 true BRPI0909749A2 (pt) 2019-02-26

Family

ID=41065787

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0909749-0A BRPI0909749A2 (pt) 2008-03-14 2009-03-10 uso de fotoiniciador para fabrico de medicamento para tratamento do ceratocone, da ectasia e fortalecimento da córnea

Country Status (10)

Country Link
US (1) US20110060267A1 (pt)
EP (1) EP2265233A2 (pt)
JP (1) JP2011514359A (pt)
KR (1) KR20110018295A (pt)
CN (1) CN101969900A (pt)
AU (1) AU2009223641A1 (pt)
BR (1) BRPI0909749A2 (pt)
CA (1) CA2715031A1 (pt)
MX (1) MX2010009923A (pt)
WO (1) WO2009114513A2 (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110098790A1 (en) * 2009-10-26 2011-04-28 Albert Daxer Methods for treating corneal disease
WO2007135173A1 (de) 2006-05-23 2007-11-29 Albert Daxer Hornhautimplantat und verfahren zur korrektur von fehlsichtigkeiten des menschlichen auges
US11246951B2 (en) * 2005-01-31 2022-02-15 S. Edward Neister Method and apparatus for sterilizing and disinfecting air and surfaces and protecting a zone from external microbial contamination
WO2011050164A1 (en) 2009-10-21 2011-04-28 Avedro, Inc. Eye therapy
WO2011116306A2 (en) 2010-03-19 2011-09-22 Avedro, Inc. Systems and methods for applying and monitoring eye therapy
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
WO2012162529A1 (en) * 2011-05-24 2012-11-29 Avedro, Inc. Systems and methods for reshaping an eye feature
WO2012167260A2 (en) 2011-06-02 2012-12-06 Avedro, Inc. Systems and methods for monitoring time based photo active agent delivery or photo active marker presence
US9023092B2 (en) 2011-08-23 2015-05-05 Anthony Natale Endoscopes enhanced with pathogenic treatment
US8668727B2 (en) 2011-08-23 2014-03-11 Anthony Natale Systems and methods for treating pathogenic infection
EP2830554A1 (en) 2012-03-29 2015-02-04 CXL Ophthalmics, LLC Ocular cross-linking system and method for sealing corneal wounds
EP4420725A3 (en) 2012-03-29 2025-04-16 Epion Therapeutics, Inc. Ocular treatment solutions, delivery devices and delivery augmentation methods
US9566301B2 (en) 2012-03-29 2017-02-14 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
EP2872081B2 (en) 2012-07-16 2025-07-16 Avedro, Inc. Systems for corneal cross-linking with pulsed light
US20140343480A1 (en) * 2013-05-19 2014-11-20 Avedro, Inc. Systems, methods, and compositions for cross-linking
WO2014205145A1 (en) 2013-06-18 2014-12-24 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
RU2542799C1 (ru) * 2013-10-29 2015-02-27 Игорь Борисович Медведев Способ лечения кератоконуса роговицы
EP3212140B1 (en) 2014-10-27 2021-12-01 Avedro, Inc. Systems for cross-linking treatments of an eye
US10114205B2 (en) 2014-11-13 2018-10-30 Avedro, Inc. Multipass virtually imaged phased array etalon
EP3827792A1 (en) 2015-04-24 2021-06-02 Avedro, Inc. Systems and methods for photoactivating a photosensitizer applied to an eye
EP4483884A3 (en) 2015-05-22 2025-03-05 Avedro Inc. Systems for monitoring cross-linking activity for corneal treatments
WO2017015471A1 (en) 2015-07-21 2017-01-26 Avedro, Inc. Systems and methods for treaments of an eye with a photosensitizer
WO2017096400A1 (en) 2015-12-03 2017-06-08 Avedro, Inc. Systems and methods for treating an eye with a mask device
US10342697B2 (en) 2016-04-13 2019-07-09 Avedro, Inc. Systems and methods for delivering drugs to an eye
WO2019070979A1 (en) 2017-10-04 2019-04-11 University Of Florida Research Foundation METHODS AND COMPOSITIONS FOR ENHANCED COMFORT CONTACT LENS
US12042433B2 (en) 2018-03-05 2024-07-23 Avedro, Inc. Systems and methods for eye tracking during eye treatment
EP3761928B1 (en) 2018-03-08 2026-07-22 Avedro, Inc. Micro-devices for treatment of an eye
CN108693267B (zh) * 2018-05-18 2020-12-08 中国烟草总公司郑州烟草研究院 4-甲基二苯甲酮纯度标准物质及其制备方法
CN113316411B (zh) 2018-09-19 2025-01-17 艾维德洛公司 用于眼部治疗期间的眼部追踪的系统及方法
CA3112937A1 (en) 2018-09-19 2020-03-26 Avedro, Inc. Systems and methods treating for corneal ectatic disorders
AU2019356934B2 (en) 2018-10-09 2024-10-17 Avedro, Inc. Photoactivation systems and methods for corneal cross-linking treatments
WO2020176598A1 (en) 2019-02-26 2020-09-03 Avedro, Inc. Systems and methods for cross-linking treatments of an eye
AU2020326998B2 (en) 2019-08-06 2024-08-22 Avedro, Inc. Photoactivation systems and methods for corneal cross-linking treatments
US11259959B1 (en) 2020-11-03 2022-03-01 D&D Biopharmaceuticals, Inc. Devices and methods for cornea treatment
CA3213111A1 (en) 2021-03-08 2022-09-15 Avedro, Inc. Systems and methods for generating patient-specific corneal cross-linking treatment patterns
US11938092B1 (en) 2022-11-30 2024-03-26 D&D Biopharmaceuticals, Inc. Devices and methods for cornea treatment
TR2023019496A1 (tr) * 2023-12-29 2025-07-21 Istinye Ueniversitesi Enjekte Edilebilir Sertleşen Biyomalzeme Uygulaması ile Korneanın Güçlendirilmesi

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4969912A (en) * 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
US5067961A (en) * 1988-02-18 1991-11-26 Autogenesis Technologies, Inc. Non-biodegradable two phase corneal implant and method for preparing same
US5201764A (en) * 1990-02-28 1993-04-13 Autogenesis Technologies, Inc. Biologically compatible collagenous reaction product and articles useful as medical implants produced therefrom
US5104957A (en) * 1990-02-28 1992-04-14 Autogenesis Technologies, Inc. Biologically compatible collagenous reaction product and articles useful as medical implants produced therefrom
US5219895A (en) * 1991-01-29 1993-06-15 Autogenesis Technologies, Inc. Collagen-based adhesives and sealants and methods of preparation and use thereof
US6161544A (en) * 1998-01-28 2000-12-19 Keratoform, Inc. Methods for accelerated orthokeratology
US6183498B1 (en) * 1999-09-20 2001-02-06 Devore Dale P. Methods and products for sealing a fluid leak in a tissue
KR101502632B1 (ko) * 2006-10-24 2015-03-17 캘리포니아 인스티튜트 오브 테크놀로지 신체 조직의 물리적 및/또는 화학적 성질에 영향을 주는 광화학적 요법

Also Published As

Publication number Publication date
MX2010009923A (es) 2010-12-17
JP2011514359A (ja) 2011-05-06
US20110060267A1 (en) 2011-03-10
KR20110018295A (ko) 2011-02-23
WO2009114513A2 (en) 2009-09-17
CA2715031A1 (en) 2009-09-17
CN101969900A (zh) 2011-02-09
WO2009114513A3 (en) 2010-01-07
EP2265233A2 (en) 2010-12-29
AU2009223641A1 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
WO2009114513A3 (en) Ultraviolet irradiation to treat corneal weakness disorders
CY1116344T1 (el) Κυτταρα προερχομενα απο ιστο ομφαλιου λωρου για την θεραπεια νευροπαθητικου πονου και σπαστικοτητας
MX2020007060A (es) Compuestos, composiciones y metodos para tratar enfermedades que involucren tejidos con enfermedades acidas o hipoxicas.
BR112013020005A8 (pt) peptídeo de fórmula geral r1-wn-xm-aa1-aa2-aa3-aa4-aa5-aa6-yp-zq-r2, seus estereoisômeros, misturas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica
BR112019001573A2 (pt) conjunto de componentes e dispositivos para aplicação de terapia de luz e métodos relacionados aos mesmos
BR112015006623A2 (pt) laquinimod e pridopidina para o tratamento de doenças neurodegenerativas
BR112015027282A8 (pt) formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet
BR112014008789A2 (pt) prevenção e tratamento de condições oculares
EA201000897A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
CY1114577T1 (el) Αποτροπη και θεραπεια υπο-κλινικης pcvd
BR112015001158A2 (pt) formulação oftálmica e respectivo uso e método para melhorar, reduzir ou tratar presbiopia
WO2009040420A3 (en) Use of a monoterpene to increase tissue repair
NO20074850L (no) Oftalmologiske sammensetninger og anvendelse derav
BR112015018252A2 (pt) composição farmacêutica aquosa de dose fixa estável para administração nasal para um ser humano, composição de suspensão aquosa farmacêutica de dose fixa estável para administração nasal para um ser humano, suspensão estável adequada para administração nasal a um ser humano, método para tratar rinite em um ser humano necessitando do mesmo, uso da composição farmacêutica para administração nasal, método para liberar uma composição farmacêutica e kit
BR112014028315A2 (pt) mposto, métodos para introdução de uma molécula dentro do citosol de uma célula, para obter a morte de uma célula, para expressar uma molécula antigênica ou uma parte da mesma na superfície de uma célula, e para tratamento ou prevenção de uma doença, distúrbio ou infecção em um paciente, composição farmacêutica, célula ou uma população de células, e, kit
BR112014003071A2 (pt) tratamento de doença vascular periférica com o uso de células derivadas do tecido do cordão umbilical
MX2022014199A (es) Usos y formulaciones de los cannabinoides.
AR046892A1 (es) Suspensiones acuosas de ciclesonida para nebulizaciones y metodo de preparacion
BR112017015387A2 (pt) composição em gel tópica, método de tratamento de uma infecção da pele, composição em gel oftálmica, e, método de tratamento de uma afecção infecciosa do olho ou pálpebra
JOP20220259A1 (ar) تركيبات تشتمل على جسيمات نانونية، طريقة تصنيعها واستخدامها
BRPI0510778A (pt) composição farmacêutica, processo para a preparação da mesma, método para o tratamento de rinite, e, uso de uma composição
WO2016060917A3 (en) Formulations for histatin therapeutics
BRPI0913665B8 (pt) composição para tratamento de pressão intraocular aumentada em um paciente, compreendendo extratos de vaccinum myrtillus e de casca de pinheiro
MX391376B (es) Composiciones de la membrana de la cáscara del huevo para usarse en el tratamiento de la cadena ligera kappa del factor nuclear de las células b activadas (nf-kb) en un organismo hospedero.
BR112013025197A2 (pt) métodos para tratar doença de alzheimer e para avaliar a eficáca de uma terapia destinada a tratar doença de alzheimer

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: VIDE PARECER

B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]